Observational studyPloS one2025

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

Karlien Mul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.